The DOI matches its Crossref record; 99 of the 99 references it cites were found in a registry or an index.
Insulin‐associated weight gain in diabetes – causes, effects and coping strategies
Abstract
Insulin therapy or intensification of insulin therapy commonly results in weight gain in both type 1 and type 2 diabetes. This weight gain can be excessive, adversely affecting cardiovascular risk profile. The spectre of weight gain can increase diabetic morbidity and mortality when it acts as a psychological barrier to the initiation or intensification of insulin, or affects adherence with prescribed regimens. Insulin‐associated weight gain may result from a reduction of blood glucose to levels below the renal threshold without a compensatory reduction in calorie intake, a defensive or unconscious increase in calorie intake caused by the fear or experience of hypoglycaemia, or the ‘unphysiological’ pharmacokinetic and metabolic profiles that follow subcutaneous administration. There is, however, scope for limiting insulin‐associated weight gain. Strategies include limiting dose by increasing insulin sensitivity through diet and exercise or by using adjunctive anorectic or insulin‐sparing pharmacotherapies such as pramlintide or metformin. Insulin replacement regimens that attempt to mimic physiological norms should also enable insulin to be dosed with maximum efficiency. The novel acylated analogue, insulin detemir, appears to lack the usual propensity for causing weight gain. Elucidation of the pharmacological mechanisms underlying this property might help clarify the mechanisms linking insulin with weight regulation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Intensive insulin therapy in critically ill patients.
Van den Berghe, G., Wouters, P., Weekers, F., Verwaest, C., Bruyninckx, F., Schetz, M., Vlasselaers, D., Ferdinande, P., Lauwers, P., & Bouillon, R. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011300 · Cited by 9,977
Stratton, I. M. (2000) · BMJ · doi:10.1136/bmj.321.7258.405 · Cited by 9,059
Weight gain as a risk factor for clinical diabetes mellitus in women
Colditz, G. A., Willett, W. C., Rotnitzky, A., & Manson, J. E. (1995) · Annals of Internal Medicine · doi:10.7326/0003-4819-122-7-199504010-00001 · Cited by 2,064
DeFronzo, R. A., Ratner, R. E., Han, J., Kim, D. D., Fineman, M. S., & Baron, A. D. (2005) · Diabetes Care · doi:10.2337/diacare.28.5.1092 · Cited by 1,559
Van Gaal, L. F., Rissanen, A. M., Scheen, A. J., Ziegler, O., & Rössner, S. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66374-x · Cited by 1,499
Riddle (2003) · doi:10.2337/diacare.26.11.3080 · Cited by 1,479
Zander, M., Madsbad, S., Madsen, J. L., & Holst, J. J. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07952-7 · Cited by 1,297
Kendall, D. M., Riddle, M. C., Rosenstock, J., Zhuang, D., Kim, D. D., Fineman, M. S., & Baron, A. D. (2005) · Diabetes Care · doi:10.2337/diacare.28.5.1083 · Cited by 1,177
Diabetes, Obesity, and the Brain
Schwartz, M. W., & Porte, D. (2005) · Science · doi:10.1126/science.1104344 · Cited by 841
Long-term weight loss after diet and exercise: a systematic review
Curioni, C. C., & Lourenço, P. M. (2005) · International Journal of Obesity · doi:10.1038/sj.ijo.0803015 · Cited by 695
The accelerator hypothesis: weight gain as the missing link between type I and type II diabetes
Wilkin, T. J. (2001) · Diabetologia · doi:10.1007/s001250100548 · Cited by 623
Heise, T., Nosek, L., Rønn, B. B., Endahl, L., Heinemann, L., Kapitza, C., & Draeger, E. (2004) · Diabetes · doi:10.2337/diabetes.53.6.1614 · Cited by 614
Wolff, L. F., Smith, Q. T., Snyder, W. K., Bedrick, J. A., Liljemark, W. F., Aeppli, D. A., & Bandt, C. L. (1988) · Journal of Clinical Periodontology · doi:10.1111/j.1600-051x.1988.tb01003.x · Cited by 577
Intentional weight loss and mortality among overweight individuals with diabetes.
Williamson, D. F., Thompson, T. J., Thun, M., Flanders, D., Pamuk, E., & Byers, T. (2000) · Diabetes Care · doi:10.2337/diacare.23.10.1499 · Cited by 558
The source of cerebral insulin
Banks, W. A. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.02.040 · Cited by 489
Purnell, J. Q., Hokanson, J. E., Marcovina, S. M., Steffes, M. W., Cleary, P. A., & Brunzell, J. D. (1998) · JAMA · doi:10.1001/jama.280.2.140 · Cited by 469
(2001) · The Journal of Pediatrics · doi:10.1067/mpd.2001.118887 · Cited by 460
When oral agents fail: practical barriers to starting insulin
Korytkowski, M. (2002) · International Journal of Obesity · doi:10.1038/sj.ijo.0802173 · Cited by 448
Importance of Weight Management in Type 2 Diabetes: Review with Meta-analysis of Clinical Studies
Anderson, J. W., Kendall, C. W. C., & Jenkins, D. J. A. (2003) · Journal of the American College of Nutrition · doi:10.1080/07315724.2003.10719316 · Cited by 448
The Mechanism of Protraction of Insulin Detemir, a Long-Acting, Acylated Analog of Human Insulin
Havelund, S., Plum, A., Ribel, U., Jonassen, I., Vølund, A., Markussen, J., & Kurtzhals, P. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000036926.54824.37 · Cited by 429
Degn, K. B., Juhl, C. B., Sturis, J., Jakobsen, G., Brock, B., Chandramouli, V., Rungby, J., Landau, B. R., & Schmitz, O. (2004) · Diabetes · doi:10.2337/diabetes.53.5.1187 · Cited by 427
Hermansen, K., Fontaine, P., Kukolja, K. K., Peterkova, V., Leth, G., & Gall, M.-A. (2004) · Diabetologia · doi:10.1007/s00125-004-1365-z · Cited by 365
Weight Gain Associated With Intensive Therapy in the Diabetes Control and Complications Trial
The DCCT Research Group (1988) · Diabetes Care · doi:10.2337/diacare.11.7.567 · Cited by 345
Insulin Signaling in the Central Nervous System
Porte, D., Baskin, D. G., & Schwartz, M. W. (2005) · Diabetes · doi:10.2337/diabetes.54.5.1264 · Cited by 336
Kurtzhals, P., Havelund, S., Jonassen, I., Kiehr, B., Larsen, U. D., Ribel, U., & Markussen, J. (1995) · Biochemical Journal · doi:10.1042/bj3120725 · Cited by 334
Bryden, K. S., Neil, A., Mayou, R. A., Peveler, R. C., Fairburn, C. G., & Dunger, D. B. (1999) · Diabetes Care · doi:10.2337/diacare.22.12.1956 · Cited by 323
Lee, A., & Morley, J. E. (1998) · Obesity Research · doi:10.1002/j.1550-8528.1998.tb00314.x · Cited by 320
Obesity, weight loss and prognosis in type 2 diabetes
Lean, M. E. J., Powrie, J. K., Anderson, A. S., & Garthwaite, P. H. (1990) · Diabetic Medicine · doi:10.1111/j.1464-5491.1990.tb01375.x · Cited by 318
Weight change and duration of overweight and obesity in the incidence of type 2 diabetes.
Wannamethee, S. G., & Shaper, A. G. (1999) · Diabetes Care · doi:10.2337/diacare.22.8.1266 · Cited by 317
Ratner, R. E., Dickey, R., Fineman, M., Maggs, D. G., Shen, L., Strobel, S. A., Weyer, C., & Kolterman, O. G. (2004) · Diabetic Medicine · doi:10.1111/j.1464-5491.2004.01319.x · Cited by 307
Mannucci, E., Ognibene, A., Cremasco, F., Bardini, G., Mencucci, A., Pierazzuoli, E., Ciani, S., Messeri, G., & Rotella, C. M. (2001) · Diabetes Care · doi:10.2337/diacare.24.3.489 · Cited by 300
Insulin Omission in Women With IDDM
Polonsky, W. H., Anderson, B. J., Lohrer, P. A., Aponte, J. E., Jacobson, A. M., & Cole, C. F. (1994) · Diabetes Care · doi:10.2337/diacare.17.10.1178 · Cited by 299
Haffner, S. M., D'Agostino, R., Mykkänen, L., Tracy, R., Howard, B., Rewers, M., Selby, J., Savage, P. J., & Saad, M. F. (1999) · Diabetes Care · doi:10.2337/diacare.22.4.562 · Cited by 297
Vague, P., Selam, J.-L., Skeie, S., De Leeuw, I., Elte, J. W. F., Haahr, H., Kristensen, A., & Draeger, E. (2003) · Diabetes Care · doi:10.2337/diacare.26.3.590 · Cited by 294
Larsen, T. M., Toubro, S., & Astrup, A. (2003) · International Journal of Obesity · doi:10.1038/sj.ijo.802223 · Cited by 282
Haak, T., Tiengo, A., Draeger, E., Suntum, M., & Waldhäusl, W. (2005) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2004.00373.x · Cited by 277
Plank, J., Bodenlenz, M., Sinner, F., Magnes, C., Görzer, E., Regittnig, W., Endahl, L. A., Draeger, E., Zdravkovic, M., & Pieber, T. R. (2005) · Diabetes Care · doi:10.2337/diacare.28.5.1107 · Cited by 271
Variability of Insulin Absorption and Insulin Action
Heinemann, L. (2002) · Diabetes Technology & Therapeutics · doi:10.1089/152091502320798312 · Cited by 267
Home, P., Bartley, P., Russell-Jones, D., Hanaire-Broutin, H., Heeg, J.-E., Abrams, P., Landin-Olsson, M., Hylleberg, B., Lang, H., Draeger, E., et al. (2004) · Diabetes Care · doi:10.2337/diacare.27.5.1081 · Cited by 254
Self-citationLeRoith, D. (2002) · The American Journal of Medicine · doi:10.1016/s0002-9343(02)01276-7 · Cited by 236
Soluble, fatty acid acylated insulins bind to albumin and show protracted action in pigs
Markussen, J., Havelund, S., Kurtzhals, P., Andersen, A. S., Halstr�m, J., Hasselager, E., Larsen, U. D., Ribel, U., Sch�ffer, L., Vad, K., et al. (1996) · Diabetologia · doi:10.1007/bf00418343 · Cited by 233
Bruce, D. G., Chisholm, D. J., Storlien, L. H., & Kraegen, E. W. (1988) · Diabetes · doi:10.2337/diab.37.6.736 · Cited by 232
Henry, R. R., Gumbiner, B., Ditzler, T., Wallace, P., Lyon, R., & Glauber, H. S. (1993) · Diabetes Care · doi:10.2337/diacare.16.1.21 · Cited by 227
Lipoprotein abnormalities and their consequences for patients with type 2 diabetes
Krentz, A. J. (2003) · Diabetes Obesity and Metabolism · doi:10.1046/j.1462-8902.2003.0310.x · Cited by 205
Group, T. D. C. A. C. T. R. (2001) · Diabetes Care · doi:10.2337/diacare.24.10.1711 · Cited by 205
Russell-Jones, D., Simpson, R., Hylleberg, B., Draeger, E., & Bolinder, J. (2004) · Clinical Therapeutics · doi:10.1016/s0149-2918(04)90072-0 · Cited by 194
Self-citationEffect of Pramlintide on Weight in Overweight and Obese Insulin‐Treated Type 2 Diabetes Patients
Hollander, P., Maggs, D. G., Ruggles, J. A., Fineman, M., Shen, L., Kolterman, O. G., & Weyer, C. (2004) · Obesity Research · doi:10.1038/oby.2004.76 · Cited by 191
De Leeuw, I., Vague, P., Selam, J. ‐., Skeie, S., Lang, H., Draeger, E., & Elte, J. W. F. (2005) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2004.00363.x · Cited by 179
Therapy of type 2 diabetes mellitus based on the actions of glucagon‐like peptide‐1
Holst, J. J. (2002) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.328 · Cited by 169
Bruttomesso, D., Pianta, A., Mari, A., Valerio, A., Marescotti, M. C., Avogaro, A., Tiengo, A., & Del Prato, S. (1999) · Diabetes · doi:10.2337/diabetes.48.1.99 · Cited by 166
Betts, P., Mulligan, J., Ward, P., Smith, B., & Wilkin, T. (2005) · Diabetic Medicine · doi:10.1111/j.1464-5491.2004.01368.x · Cited by 164
Metformin as an Adjunct Therapy in Adolescents With Type 1 Diabetes and Insulin Resistance
Hamilton, J., Cummings, E., Zdravkovic, V., Finegood, D., & Daneman, D. (2003) · Diabetes Care · doi:10.2337/diacare.26.1.138 · Cited by 161
Inhibition of dipeptidyl peptidase IV activity by oral metformin in Type 2 diabetes
Lindsay, J. R., Duffy, N. A., McKillop, A. M., Ardill, J., O'Harte, F. P. M., Flatt, P. R., & Bell, P. M. (2005) · Diabetic Medicine · doi:10.1111/j.1464-5491.2005.01461.x · Cited by 158
Intensive insulin therapy and weight gain in IDDM
Carlson, M. G., & Campbell, P. J. (1993) · Diabetes · doi:10.2337/diab.42.12.1700 · Cited by 155
Basu, A., Jensen, M. D., McCann, F., Mukhopadhyay, D., Joyner, M. J., & Rizza, R. A. (2006) · Diabetes Care · doi:10.2337/diacare.29.03.06.dc05-2004 · Cited by 144
Enhanced secretion of glucagon-like peptide 1 by biguanide compounds
Yasuda, N., Inoue, T., Nagakura, T., Yamazaki, K., Kira, K., Saeki, T., & Tanaka, I. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)02565-2 · Cited by 137
Purnell, J. Q., & Weyer, C. (2003) · Treatments in Endocrinology · doi:10.2165/00024677-200302010-00004 · Cited by 126
Pieber, T. R., Draeger, E., Kristensen, A., & Grill, V. (2005) · Diabetic Medicine · doi:10.1111/j.1464-5491.2005.01545.x · Cited by 122
Basal and 24-h C-peptide and insulin secretion rate in normal man
Kruszynska, Y. T., Home, P., Hanning, I., & Alberti, K. G. M. M. (1987) · Diabetologia · doi:10.1007/bf01788901 · Cited by 121
Effect of Obesity on the Response to Insulin Therapy in Noninsulin-Dependent Diabetes Mellitus
Yki‐Järvinen, H., Ryysy, L., Kauppila, M., Kujansuu, E., Lahti, J., Marjanen, T., NISKANEN, L. K., Rajala, S., Salo, S., Seppälä, P., et al. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.12.4460 · Cited by 118
Leong, K. S., & Wilding, J. P. H. (1999) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1053/beem.1999.0017 · Cited by 117
Purnell, J. Q., Dev, R., Steffes, M. W., Cleary, P. A., Palmer, J. P., Hirsch, I. B., Hokanson, J. E., & Brunzell, J. D. (2003) · Diabetes · doi:10.2337/diabetes.52.10.2623 · Cited by 113
Maheux, P., Ducros, F., Bourque, J., Garon, J., & Chiasson, J. L. (1997) · International Journal of Obesity · doi:10.1038/sj.ijo.0800372 · Cited by 112
Hordern, S. V. M., Wright, J. E., Umpleby, A. M., Shojaee‐Moradie, F., Amiss, J., & Russell-Jones, D. L. (2005) · Diabetologia · doi:10.1007/s00125-005-1670-1 · Cited by 109
Self-citationUmpleby, A. M., Boroujerdi, M. A., Brown, P. M., Carson, E. R., & Sönksen, P. H. (1986) · Diabetologia · doi:10.1007/bf02427082 · Cited by 103
Body Weight Patterns From 20 to 49 Years of Age and Subsequent Risk for Diabetes Mellitus
Brancati, F. L., Nae-Yuh, W., Mead, L. A., Liang, K.-Y., & Klag, M. J. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.9.957 · Cited by 101
Spiegelman, B. M. (1997) · PubMed · Cited by 101
Growth Hormone and Diabetes mellitus
Sönksen, P. H., Russell-Jones, D. L., & Jones, R. H. (2008) · Hormone Research · doi:10.1159/000183770 · Cited by 99
Self-citationStandl, E., Lang, H., & Roberts, A. (2004) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2004.6.579 · Cited by 99
Antiatherogenic properties of metformin: the experimental evidence
Mamputu, J., Wiernsperger, N. F., & Renier, G. (2003) · Diabetes & Metabolism · doi:10.1016/s1262-3636(03)72790-6 · Cited by 93
Hanaire, H. P., Sallerin-Caute, B., Poncet, M. F., Tauber, M., Bastide, R., Chal�, J. J., Rosenfeld, R. G., & Tauber, J.-P. (1996) · Diabetologia · doi:10.1007/s001250050604 · Cited by 93
Schwartz, M. W., & Niswender, K. D. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0906 · Cited by 93
Snoek, F. J. (2002) · PubMed · Cited by 83
Bruttomesso, D., Pianta, A., Crazzolara, D., Scaldaferri, E., Lora, L., Guarneri, G., Mongillo, A., Gennaro, R., Miola, M., Moretti, M., et al. (2002) · Diabetic Medicine · doi:10.1046/j.1464-5491.2002.00750.x · Cited by 83
Douek, I. F., Allen, S., Ewings, P., Gale, E. A. M., Bingley, P. J., & for the Metformin Trial Group (2005) · Diabetic Medicine · doi:10.1111/j.1464-5491.2005.01475.x · Cited by 79
New insulins in the treatment of diabetes mellitus
Lindholm, A. (2002) · Best Practice & Research Clinical Gastroenterology · doi:10.1053/bega.2002.0321 · Cited by 79
Improving survival with metformin: the evidence base today
Scarpello, J. H. B. (2003) · Diabetes & Metabolism · doi:10.1016/s1262-3636(03)72786-4 · Cited by 71
NOVEL FORMS OF INSULIN DELIVERY
Saudek, C. D. (1997) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(05)70269-3 · Cited by 69
Diabetes Disease Stage Predicts Weight Loss Outcomes with Long‐Term Appetite Suppressants
Khan, M. A., Peter, J. V. S., Breen, G. A., Hartley, G. G., & Vessey, J. T. (2000) · Obesity Research · doi:10.1038/oby.2000.7 · Cited by 64
Ratner, R. E., Whitehouse, F. W., Fineman, M. S., Strobel, S. A., Shen, L. Z., Maggs, D., Kolterman, O., & Weyer, C. (2005) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-2005-837662 · Cited by 62
Hollander, P. A., Ratner, R. E., Fineman, M. S., Strobel, S. A., Shen, L. Z., Maggs, D. G., Kolterman, O., & Weyer, C. (2003) · Diabetes Obesity and Metabolism · doi:10.1046/j.1463-1326.2003.00295.x · Cited by 59
Aas, A., Bergstad, I., Thorsby, P. M., Johannesen, Ø., Solberg, M., & Birkeland, K. I. (2005) · Diabetic Medicine · doi:10.1111/j.1464-5491.2005.01421.x · Cited by 59
Scheen, A. J., & Ernest, P. (2002) · PubMed · Cited by 58
Usefulness of Fluoxetine in Obese Non‐Insulin‐Dependent Diabetics: A Multicenter Study
Daubresse, J., Kolanowski, J., Krzentowski, G., Kutnowski, M., Scheen, A. J., & Gaal, L. V. (1996) · Obesity Research · doi:10.1002/j.1550-8528.1996.tb00247.x · Cited by 58
Markovic, T., Campbell, L. V., Balasubramanian, S., Jenkins, A. B., Fleury, A. C., Simons, L. A., & Chisholm, D. J. (1998) · Diabetes Care · doi:10.2337/diacare.21.5.695 · Cited by 55
Malabu, U. H., McCarthy, H. D., McKibbin, P. E., & Williams, G. (1992) · Peptides · doi:10.1016/0196-9781(92)90013-s · Cited by 52
Reaven, G. M. (1985) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1985.tb02272.x · Cited by 47
Orosco, M., Rouch, C., & Gerozissis, K. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02449-5 · Cited by 45
Limitations to subcutaneous insulin administration in type 1 diabetes
Chen, J., Christiansen, J. S., & Lauritzen, T. (2003) · Diabetes Obesity and Metabolism · doi:10.1046/j.1463-1326.2003.00266.x · Cited by 41
Protein anabolic action of insulin, growth hormone and insulin-like growth factor I
Russell-Jones, D. L., & Umpleby, A. M. (1996) · European Journal of Endocrinology · doi:10.1530/eje.0.1350631 · Cited by 40
Self-citationOrosco, M., & Gerozissis, K. (2001) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(01)00004-5 · Cited by 29
Escalante-Pulido, M., Herrera, A. E., Nájar, M. E. M., & Salazar, M. A. (2003) · PubMed · Cited by 27
Long Term Safety and Efficacy of Intraperitoneal Insulin Infusion by Means of Implantable Pumps
Pinget, M., & Jeandidier, N. (1998) · Hormone and Metabolic Research · doi:10.1055/s-2007-978916 · Cited by 25
Johnson, M. L., Krosnick, A., Carson, P., McDade, A. M., & Laraway, K. (1998) · Clinical Therapeutics · doi:10.1016/s0149-2918(98)80132-x · Cited by 23
Efficacy of Insulin Pump Therapy: Mealtime Delivery is the Key Factor
Crawford, L. M., Sinha, R. N. P., O’Dell, R. M., & Comi, R. J. (2000) · Endocrine Practice · doi:10.4158/ep.6.3.239 · Cited by 16
Metabolic control and body mass index in patients with type 1 diabetes on different insulin regimens
Kulenović, I., Rašić, S., & Grujic, M. (2004) · Biomolecules and Biomedicine · doi:10.17305/bjbms.2004.3456 · Cited by 9
Markovic, T., Furler, S. M., Jenkins, A. B., Campbell, L. V., Kraegen, E. W., & Chisholm, D. J. (1995) · Diabetic Medicine · doi:10.1111/j.1464-5491.1995.tb00535.x · Cited by 8
Cited by
Neurobiology of food intake in health and disease
Morton, G. J., Meek, T. H., & Schwartz, M. W. (2014) · Nature Reviews Neuroscience · doi:10.1038/nrn3745 · Cited by 748
Brain Insulin Resistance at the Crossroads of Metabolic and Cognitive Disorders in Humans
Kullmann, S., Heni, M., Hallschmid, M., Fritsche, A., Preissl, H., & Häring, H.-U. (2016) · Physiological Reviews · doi:10.1152/physrev.00032.2015 · Cited by 622
Rosenstock, J., Davies, M., Home, P. D., Larsen, J., Koenen, C., & Schernthaner, G. (2008) · Diabetologia · doi:10.1007/s00125-007-0911-x · Cited by 447
“The mechanism(s) responsible for relatively lower weight gain observed here and previously with insulin detemir remain the object of speculation [14, 15, 21, 22].”
BackgroundJendle, J., Nauck, M. A., Matthews, D. R., Frid, A., Hermansen, K., Düring, M., Zdravkovic, M., Strauss, B. J., Garber, A. J., & Groups, O. B. O. T. L. A. L. S. (2009) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2009.01158.x · Cited by 312
Review of head‐to‐head comparisons of glucagon‐like peptide‐1 receptor agonists
Madsbad, S. (2016) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12596 · Cited by 305
Metadata
- Authors
- Russell‐Jones, D., & Khan, R.
- Venue
- Diabetes, Obesity and Metabolism
- Publisher
- Wiley
- Published
- 2006-12-15
- Volume
- 9
- Issue
- 6
- Pages
- 799-812
- ISSN
- 1462-8902 (ISSN-L)
- 1463-1326
- OpenAlex
- W2073977794
- Cited by
- 557
- References
- 99
- FWCI
- 5.45
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.